Admission of Further Securities to Trading
Puma VCT 13 plc (the "Company")
Notification of Admission of Further Securities to Trading (PRM 1.6.4R)
Further to the Company's Issue of Equity announcement on 28 August 2026 in respect of the allotment of new Ordinary Shares under the Company's Offer for Subscription and following the admission to trading of those new Ordinary Shares, the following additional information is disclosed in accordance with The Public Offers and Admissions to Trading Regulations 2024 (POATRs) PRM 1.6.4R.
1
Details of the issuer
a)
Name
Puma VCT 13 plc
b)
LEI
213800RT5DKKL9FMGO10
2
Details of the transferable securities admitted to trading
a)
Name, type and identification code
Ordinary Shares of £0.0005
ISIN: GB00BD5B1L68
b)
Regulated market
London Stock Exchange - Main Market
c)
Number of further securities admitted
1,208,301
d)
Total number of securities in issue following admission
207,427,398
e)
Fungibility
Fully fungible with existing Ordinary Shares
3
Admission details
a)
Date of admission
2 September 2026
b)
Prospectus information
Prospectus: 24 September 2025
Supplementary Prospectuses: 26 June 2026
Company's webpage: https://www.pumainvestments.co.uk/products/venture-capital-trusts/puma-vct-13
c)
Coverage of notification
The admission on 2 September 2026
4
Contact details
a)
Name and contact number
Eliot Kaye, Company Secretary, Puma VCT 13 Plc Tel: 020 7468 7900
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDADMEADNAEFDKEFA
